PennyStocksUpdate.biz is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
New York, NY -- (SBWIRE) -- 03/13/2013 -- Crossroads Systems Inc. (NASDAQ:CRDS) reported Tuesday a first-quarter loss of $3.1 million and revenue of $3.5 million compared with a loss of $2.7 million and revenue of $2.5 million during the same period last year.
The report of increased losses comes days after the Austin-based company disclosed plans to lay off nearly one fourth of its employees to save about $5 million per year.
Crossroads Systems (Nasdaq: CRDS) are scheduled to eliminate 30 jobs, most of them in research and development. The company employs 129 workers.Crossroads Systems, which was founded in 1996, develops software designed to connect and protect data for enterprise storage and cloud computing.
How Should Investors Trade CRDS Now? Find Out Here
Clearsign Combustion Corp. (NASDAQ: CLIR) a development stage company that focuses on designing and developing technologies that enhance the energy efficiency, emissions control, and fuel flexibility characteristics of combustion systems worldwide is currently up (+15.72%) on 548,858 shares traded after a Clear Sign is Selected to Present at American Flame Research Committee 2013 Industrial Combustion Symposium on September 22 - 25, 2013. Clearsign Combustion Corp. (NASDAQ:CLIR) is currently up (+87.25%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.
Click Here to find out what other Investors are saying about Clearsign Combustion Corp. (NASDAQ:CLIR)
Opexa Therapeutics Inc.(NASDAQ:OPXA) gained 14.5% to close at $2.20 after trading 1.25 million shares. Opexa is a biotechnology company focusing on the development of patient specific cellular therapies for the treatment of autoimmune diseases, and its lead product Tcelna, has the potential to address the significant unmet medical needs of the large multiple sclerosis (MS) patient population. The company traded the last 52 weeks in the range $1.07-$5.19 and institutions owned 7% of the stock. The current market cap of the company has been just under $13 million.
How Should Investors React To OPXA Now? Find out here.
Tandy Leather Factory Inc., (NASDAQ:TLF) trading at $6.91 rose $0.74 or 12.03% on a volume of 35,508 shares.Tandy Leather Factory saw fourth-quarter net income jump 29 percent as the retailer continues to expand the size of its stores to boost sales.Tandy earned $2.2 million, or 22 cents per share, for the three months ended Dec. 31 which is up from $1.7 million, or 17 cents per share, a year earlier. Revenue also increased 9 percent to $20.6 million, after dipping in 2007, it has jumped every year since the company posted annual sales of $53.3 million in 2008. At the end of 2012, revenue totaled $72.7 million, up 10 percent from the previous year.
Can SPY Continue To Move Higher? Find Out Here
Neither PennyStocksUpdate.biz nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by PennyStocksUpdate.biz, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.PennyStocksUpdate.biz makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through PennyStocksUpdate.biz. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)